Electronic cigarettes: Overview of chemical composition and exposure estimation

Tobacco Induced Diseases

Volumn 12, Issue 1, 2014, Pages

  Hahn, Jörgen ^a   Monakhova, Yulia B ^b,c,d   Hengen, Julia ^b   Kohl Himmelseher, Matthias ^b   Schössler, Jörg ^b   Hahn, Harald ^a   Kuballa, Thomas ^b   Lachenmeier, Dirk W ^b  

^a Chemisches und Veterinäruntersuchungsamt CVUA Sigmaringen   (Germany)

^b Chemisches und Veterinaruntersuchungsamt CVUA Karlsruhe   (Germany)

^c SARATOV STATE UNIVERSITY   (Russian Federation)

^d BRUKER BIOSPIN GMBH   (Germany)

Author keywords

Electronic cigarettes; Electronic nicotine delivery systems; Nicotine; Risk assessment

Indexed keywords

1,3 PROPANEDIOL; ABSINTHOL; ETHYL VANILLIN; ETHYLENE GLYCOL; FLAVORING AGENT; GLYCEROL; NICOTINE; PROPYLENE GLYCOL; SOLVENT; UNCLASSIFIED DRUG; VANILLIN;

ARTICLE; CHEMICAL COMPOSITION; ELECTRONIC CIGARETTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PRODUCT SAFETY; RISK ASSESSMENT; TOXICITY TESTING;

EID: 84989182900     PISSN: None     EISSN: 16179625     Source Type: Journal    
DOI: 10.1186/s12971-014-0023-6     Document Type: Article

References (65)

1. Yamin CK, Bitton A, Bates DW: E-cigarettes: A rapidly growing internet phenomenon. Ann Intern Med 2010, 153:607-609.
2. Regan AK, Promoff G, Dube SR, Arrazola R: Electronic nicotine delivery systems: Adult use and awareness of the 'e-cigarette' in the USA. Tob Control 2011, 22:19-23.
3. Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E, Bocchietto E, Todeschi S, Tsiapras D, Kyrzopoulos S, Voudris V: Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013, 10:5146-5162.
4. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE: Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol 2013, 25:354-361.
5. Odum LE, O'Dell KA, Schepers JS: Electronic cigarettes: do they have a role in smoking cessation? J Pharm Pract 2012, 25:611-614.
6. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE: A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemol Biomarkers Prev 2010, 19:1945-1953.
7. Flouris AD, Poulianiti KP, Chorti MS, Jamurtas AZ, Kouretas D, Owolabi EO, Tzatzarakis MN, Tsatsakis AM, Koutedakis Y: Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol 2012, 50:3600-3603.
8. Trtchounian A, Williams M, Talbot P: Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res 2013, 12:905-912.
9. Foulds J, Veldheer S, Berg A: Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract 2011, 65:1037-1042.
10. Laugesen M: Safety Report on the Ruyan E-cigarette Cartridge and Inhaled Aerosol. Christchurch, New Zealand: Health New Zealand Ltd; 2008. Retrieved from http://www.healthnz.co.nz/RuyanCartridgeReport30-Oct-08.pdf.
11. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C: Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: A prospective 6-month pilot study. BMC Public Health 2011, 11:786.
12. Lindsay JC: Technical Review and Analysis of FDA Report: "Evaluation of Ecigarettes". Houston, TX, USA: Exponent Health Sciences; 2009. Retrieved from http://truthaboutecigs.com/science/2.pdf.
13. Trehy ML, Ye W, Handwiger ME, Moore TW, Allgire JF, Woodruff JT, Ahadi SS, Black JC, Westenberger BJ: Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chrom Rel Technol 2011, 34:1442-1458.
14. Thomas B: Njoy Study to Determine Presence of TSNAs in Njoy Vapor. Houston, TX, USA: Ben Thomas Group , LLC; 2009. Retrieved from http://casaa.org/uploads/Study-TSNAs-in-NJOY-Vapor.pdf.
15. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger BJ: Identification of amino-Tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A 2010, 1217:7547-7555.
16. Alliance Technologies: Characterization of Regal Cartridges for Electronic Cigarettes-Phase II. Monmouth Junction, NJ, USA: Alliance Technologies; 2009. Retrieved from http://truthaboutecigs.com/science/9.pdf.
17. Etter JF, Zather E, Svensson S: Analysis of refill liquids for electronic cigarettes. Addiction 2013, 108:1671-1679.
18. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L: Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013, 15:158-166.
19. Goniewicz ML, Hajek P, McRobbie H: Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 2014, 109:500-507.
20. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Peyton IJ, Benowitz N: Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014, 23:133-139.
21. Monakhova YB, Kuballa T, Löbell-Behrends S, Maixner S, Kohl-Himmelseher M, Ruge W, Lachenmeier DW: Standardless 1H NMR determination of pharmacology active substances in dietary supplements and medicines that have been illegaly traded over the Internet. Drug Test Anal 2012, 5:400-411.
22. Maes P, Monakhova YB, Kuballa T, Reusch H, Lachenmeier DW: Qualitative and quantitative control of carbonated cola beverages using 1H NMR spectroscopy. J Agric Food Chem 2012, 60:2778-2784.
23. BfR: Liquids from E-cigarettes can be Detrimental to Health. BfR Opinion No. 016/2012. Berlin, Germany: Federal Institute for Risk Assessment; 2012. Retrieved from http://www.bfr.bund.de/cm/349/liquids-from-e-cigarettescan-be-detrimental-To-health.pdf.
24. Lachenmeier DW, Breaux TA, Kuballa T, Schlee C, Monakhova YB: Composition of distilled Perique tobacco liqueur: A connoisseur's spirit or a health risk due to nicotine? Food Chem 2014, 159:230-235.
25. German Institute for Standardization: DIN 32 645. Chemical Analysis-Decision Limit, Detection Limit and Determination Limit Under Repeatability Conditions-Terms, Methods, Evaluation. Berlin, Germany: Beuth Verlag; 2008.
26. Lachenmeier DW, Przybylski MC, Rehm J: Comparative risk assessment of carcinogens in alcoholic beverages using the margin of exposure approach. Int J Cancer 2012, 131:E995-E1003.
27. Lachenmeier DW, Rehm J: Unrecorded alcohol-no worries besides ethanol: A population-based probabilistic risk assessment. In Alcohol Policy in Europe: Evidence from AMPHORA. 2nd edition. Edited by Anderson P, Braddick F, Reynolds J, Gual A. Barcelona, Spain: Alcohol Measures for Public Health Research Alliance (AMPHORA); 2013:118-130.
28. Lachenmeier DW, Godelmann R, Witt B, Riedel K, Rehm J: Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic dose-response assessment. Int J Cancer 2014, 134:144-153.
29. Lachenmeier DW, Wegert K, Kuballa T, Schneider R, Ruge W, Reusch H, Alexy U, Kersting M, Winkler G: Caffeine intake from beverages in German children, adolescents, and adults. J Caffeine Res 2013, 3:47-53.
30. EFSA: Potential risks for public health due to the presence of nicotine in wild mushrooms. EFSA J 2009, RN-286:1-47.
31. OECD SIDS: Glycerol CAS No: 56-81-5. Nairobi, Kenya: UNEP Publications; 2002.
32. JECFA: 1, 2-Propylene glycol. In WHO Food Additives Series 5. Toxicological Evaluation of Some Food Additives Including Anticaking Agents, Antimicrobials, Antioxidants, Emulsifiers, and Thickening Agents. Geneva, Switzerland: World Health Organization; 1974:275-277.
33. ATSDR: Toxicological Profile for Ethylene glycol. Atlanta, Georgia: U.S. Department of Health and Human Services. Public Health Service. Agency for Toxic Substances and Disease Registry; 2010.
34. EFSA Panel on Contaminants in the Food Chain: Scientific Opinion on the evaluation of the substances currently on the list in the annex to Commission Directive 96/3/EC as acceptable previous cargoes for edible fats and oils-Part III of III. EFSA J 2012, 10:2984.
35. JECFA: Ethyl vanillin. In WHO Food Additives Series 35. Toxicological Evaluation of Certain Food Additives and Contaminants. Geneva, Switzerland: World Health Organization; 1996:141-154.
36. Lachenmeier DW, Uebelacker M: Risk assessment of thujone in foods and medicines containing sage and wormwood-evidence for a need of regulatory changes? Regul Toxicol Pharmacol 2010, 58:437-443.
37. U.S.EPA: The Use of the Benchmark Dose Approach in Health Risk Assessment. EPA/630/R-94/007. Washington, DC: Office of Research and Development. US Environmental Protection Agency; 1995.
38. EFSA: Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J 2005, 282:1-31.
39. Medeiros Vinci R, Jacxsens L, Van Loco J, Matsiko E, Lachat C, de Schaetzen T, Canfyn M, Van Overmeire I, Kolsteren P, De Meulenaer B: Assessment of human exposure to benzene through foods from the Belgian market. Chemosphere 2012, 88:1001-1007.
40. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V: Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse 2013, 7:139-146.
41. EFSA Scientific Committee: Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. EFSA J 2012, 10:2579.
42. Lindgren M, Molander L, Verbaan C, Lunell E, Rosen I: Electroencephalographic effects of intravenous nicotine-A dose-response study. Psychopharmacol (Berl) 1999, 145:342-350.
43. Hine CH, Anderson HH, Moon HD, Dunlap MK, Morse MS: Comparative toxicity of synthetic and natural glycerin. AMA Arch Ind Hyg Occup Med 1953, 7:282-291.
44. Gaunt IF, Carpanini FM, Grasso P, Lansdown AB: Long-Term toxicity of propylene glycol in rats. Food Cosmet Toxicol 1972, 10:151-162.
45. Weil CS, Woodside MD, Smyth HF Jr, Carpenter CP: Results of feeding propylene glycol in the diet to dogs for two years. Food Cosmet Toxicol 1971, 9:479-490.
46. Neeper-Bradley TL, Tyl RW, Fisher LC, Kubena MF, Vrbanic MA, Losco PE: Determination of a no-observed-effect level for developmental toxicity of ethylene glycol administered by gavage to CD rats and CD-1 mice. Fundam Appl Toxicol 1995, 27:121-130.
47. Tyl RW, Ballantyne B, France KA, Fisher LC, Klonne DR, Pritts IM: Evaluation of the developmental toxicity of ethylene glycol monohexyl ether vapor in Fischer 344 rats and New Zealand white rabbits. Fundam Appl Toxicol 1989, 12:269-280.
48. NTP: Toxicology and carcinogenesis studies of a, b-Thujone (Cas No. 76231-76-0) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 2011, 570:1-260.
49. Westenberger BJ: Evaluation of E-cigarettes. DPATR-FY-09-23. St. Lous, MO: FDA Department of Health & Human Services; 2009. Retrieved from http://truthaboutecigs.com/science/1.pdf.
50. Alliance Technologies: Chemical Composition of "Instead" Electronic Cigarette Smoke Juice and Vapour. Monmouth Junction, NJ, USA: Alliance Technologies; 2009. Retrieved from http://truthaboutecigs.com/science/13.pdf.
51. Alliance Technologies: Characterization of Liquid "Smoke Juice" for Electronic Cigarettes. Monmouth Junction, NJ, USA: Alliance Technologies; 2009. Retrieved from http://truthaboutecigs.com/science/4.pdf.
52. Monakhova YB, Tsikin AM, Kuballa T, Lachenmeier DW, Mushtakova SP: Independent component analysis (ICA) algorithms for improved spectral deconvolution of overlapped signals in 1H NMR analysis: Application to foods and related products. Magn Reson Chem 2014, 52:231-240.
53. Lambe J: The use of food consumption data in assessments of exposure to food chemicals including the application of probabilistic modelling. Proc Nutr Soc 2002, 61:11-18.
54. Gibney MJ, van der Voet H: Introduction to the Monte Carlo project and the approach to the validation of probabilistic models of dietary exposure to selected food chemicals. Food Addit Contam 2003, 20(Suppl 1):S1-S7.
55. IPCS: Environmental Health Criteria 240: Principles and Methods for the Risk Assessment of Chemicals in Food. Geneva: World Health Organization; 2009.
56. Mayer B: How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch Toxicol 2014, 88:5-7.
57. Ginzkey C, Kampfinger K, Friehs G, Kohler C, Hagen R, Richter E, Kleinsasser NH: Nicotine induces DNA damage in human salivary glands. Toxicol Lett 2009, 184:1-4.
58. Ginzkey C, Steussloff G, Koehler C, Hackenberg S, Richter E, Hagen R, Kleinsasser NH: Nicotine causes genotoxic damage but is not metabolized during long-Term exposure of human nasal miniorgan cultures. Toxicol Lett 2014, 229:303-310.
59. Ginzkey C, Steussloff G, Koehler C, Burghartz M, Scherzed A, Hackenberg S, Hagen R, Kleinsasser NH: Nicotine derived genotoxic effects in human primary parotid gland cells as assessed in vitro by comet assay, cytokinesis-block micronucleus test and chromosome aberrations test. Toxicol In Vitro 2014, 28:838-846.
60. Catassi A, Servent D, Paleari L, Cesario A, Russo P: Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res 2008, 659:221-231.
61. Schroeder MJ, Hoffman AC: Electronic cigarettes and nicotine clinical pharmacology. Tob Control 2014, 23(Suppl 2):ii30-ii35.
62. FDA: CFR-Code of Federal Regulations Title 21. Foods and Drugs. Chapter I. Subchapter B. Part 184-Direct Food Substances Affirmed as Generally Recognized as Safe. Silver Spring, MD, USA: U.S. Food and Drug Administration; 2013.
63. Lachenmeier DW, Steffen C, El-Atma O, Maixner S, Löbell-Behrends S, Kohl-Himmelseher M: What is a food and what is a medicinal product in the European Union? Use of the benchmark dose (BMD) methodology to define a threshold for "pharmacological action". Regul Toxicol Pharmacol 2012, 64:286-295.
64. European Commission: E-cigarettes myth buster. 2014 [http://ec.europa.eu/health/tobacco/docs/tobacco-mythbuster-en.pdf]
65. European Commission: E-cigarettes. 2014 [http://ec.europa.eu/health/tobacco/docs/fs-ecigarettes-en.pdf]